Revisiting Recommendations on Drug Resistance from Past Studies
•Download as PPT, PDF•
1 like•688 views
The document summarizes recommendations from various sources to address the problem of antimicrobial resistance. It outlines recommendations in three areas: health systems, behavior changes, and technology developments. For each area, it lists specific recommendations, the organizations that proposed them, and considerations around implementation such as targeted stakeholders and timeframes. Key recommendations include improving regulation and surveillance of antimicrobial use, optimizing treatment guidelines, educating providers and patients, developing new diagnostics and drugs, and providing incentives for research and development.
Report
Share
Report
Share
![Mapping Out Emerging Solution Areas ,[object Object],[object Object],[object Object],Group Discussion: What’s worked, what hasn’t, and where we can make a difference.](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recommended
Generic drug
This slide contains what is generic drug, what is advantages & disadvantages,reason behind unpopularity of generic drug in India, why generic drugs are important in India, why there is a need of generic drug policy, who are the regulatory authority, what are the act & laws, what policy existing in India for generic drug then Conclusion.
Drug Bulletin of Nepal
The document summarizes several important drug regulatory news and safety updates from regulatory authorities including Health Canada and the US FDA. It provides warnings and updates to healthcare professionals in Nepal about potential drug interactions and risks, including:
1) The risk of high anion gap metabolic acidosis with concomitant use of flucloxacillin and paracetamol.
2) The possible risk of hypothyroidism in infants given iodine-containing contrast agents.
3) The removal of a boxed warning about asthma deaths for medicines containing inhaled corticosteroids and long-acting beta agonists.
4) The rare risk of subacute cutaneous lupus erythematosus with proton
Drug Bulletin Of Nepal
The FDA has warned of rare but serious allergic reactions occurring with products containing chlorhexidine gluconate, an antiseptic commonly used in skin preparations before surgery and injections. While rare, reports of serious allergic reactions have increased in recent years. The FDA identified 52 cases of anaphylaxis associated with chlorhexidine gluconate products applied to the skin between 1969-2015, including two deaths. Health professionals are advised to be aware of the risk of serious allergic reactions when using chlorhexidine gluconate products.
Generic medicines in india promulgating growth & access
The document discusses generics medicines in India. It notes that the Indian pharmaceutical market is predominantly a branded generics market, with generics accounting for around 90% of total sales. The government of India is focused on boosting generics growth within India and for exports. However, the generics industry faces challenges from regulatory/licensing issues. The conference aims to address these challenges and find solutions to promote the generics industry in India.
National drug policy of Nepal
The document discusses Nepal's national drug policies from 1991 to present. It provides the following key points:
1. Nepal introduced its first National Health Policy in 1991 to improve rural health access. This led to a National Drug Policy in 1995 to ensure availability of safe, effective drugs at affordable prices nationwide.
2. The drug policy has been revised over time, with the 2007 revision strengthening regulatory authorities and encouraging research collaboration. It aims to improve drug management, quality assurance, rational use, and develop the domestic drug industry.
3. Considerable progress has been made in achieving many of the drug policy's objectives, such as establishing quality control laboratories, increasing domestic drug production, and implementing drug information systems. However,
Guidelines for Drug Donation to Nepal (DDA)
1. This document provides guidelines for drug donations in Nepal to ensure donated drugs meet national requirements and are based on expressed needs.
2. Key guidelines include that donated drugs must be approved for use in Nepal, have sufficient shelf life remaining, come from reliable sources that meet quality standards, and be appropriately packaged and labeled.
3. The recipient organization is responsible for informing donors of needs and ensuring proper storage, handling, and administration of donated drugs.
Essential medicines and counterfeit medicines
The document discusses essential medicines and counterfeit medicines. It defines essential medicines as those that satisfy the priority health needs of a population and are selected based on disease prevalence, efficacy, safety and cost-effectiveness. The WHO publishes a Model List of Essential Medicines every two years to guide countries in developing their own lists. Counterfeit medicines pose serious risks as they may contain incorrect ingredients, too much or too little of the active ingredient, or no active ingredient at all. It is difficult to determine the full extent of counterfeiting due to varying reporting methods across countries and regions. Counterfeiting is most prevalent in areas with weak regulatory and enforcement systems for medicines.
OTC Drug Market - Future Growth Driver for IPM
India is one of the emerging markets which is offering significant growth potential for the industry. This presentation provides a glance of Indian Pharmaceutical Market with more insights into Indian OTC drug markets, its current scenario as well as strategies for ensuring higher sales returns.
Recommended
Generic drug
This slide contains what is generic drug, what is advantages & disadvantages,reason behind unpopularity of generic drug in India, why generic drugs are important in India, why there is a need of generic drug policy, who are the regulatory authority, what are the act & laws, what policy existing in India for generic drug then Conclusion.
Drug Bulletin of Nepal
The document summarizes several important drug regulatory news and safety updates from regulatory authorities including Health Canada and the US FDA. It provides warnings and updates to healthcare professionals in Nepal about potential drug interactions and risks, including:
1) The risk of high anion gap metabolic acidosis with concomitant use of flucloxacillin and paracetamol.
2) The possible risk of hypothyroidism in infants given iodine-containing contrast agents.
3) The removal of a boxed warning about asthma deaths for medicines containing inhaled corticosteroids and long-acting beta agonists.
4) The rare risk of subacute cutaneous lupus erythematosus with proton
Drug Bulletin Of Nepal
The FDA has warned of rare but serious allergic reactions occurring with products containing chlorhexidine gluconate, an antiseptic commonly used in skin preparations before surgery and injections. While rare, reports of serious allergic reactions have increased in recent years. The FDA identified 52 cases of anaphylaxis associated with chlorhexidine gluconate products applied to the skin between 1969-2015, including two deaths. Health professionals are advised to be aware of the risk of serious allergic reactions when using chlorhexidine gluconate products.
Generic medicines in india promulgating growth & access
The document discusses generics medicines in India. It notes that the Indian pharmaceutical market is predominantly a branded generics market, with generics accounting for around 90% of total sales. The government of India is focused on boosting generics growth within India and for exports. However, the generics industry faces challenges from regulatory/licensing issues. The conference aims to address these challenges and find solutions to promote the generics industry in India.
National drug policy of Nepal
The document discusses Nepal's national drug policies from 1991 to present. It provides the following key points:
1. Nepal introduced its first National Health Policy in 1991 to improve rural health access. This led to a National Drug Policy in 1995 to ensure availability of safe, effective drugs at affordable prices nationwide.
2. The drug policy has been revised over time, with the 2007 revision strengthening regulatory authorities and encouraging research collaboration. It aims to improve drug management, quality assurance, rational use, and develop the domestic drug industry.
3. Considerable progress has been made in achieving many of the drug policy's objectives, such as establishing quality control laboratories, increasing domestic drug production, and implementing drug information systems. However,
Guidelines for Drug Donation to Nepal (DDA)
1. This document provides guidelines for drug donations in Nepal to ensure donated drugs meet national requirements and are based on expressed needs.
2. Key guidelines include that donated drugs must be approved for use in Nepal, have sufficient shelf life remaining, come from reliable sources that meet quality standards, and be appropriately packaged and labeled.
3. The recipient organization is responsible for informing donors of needs and ensuring proper storage, handling, and administration of donated drugs.
Essential medicines and counterfeit medicines
The document discusses essential medicines and counterfeit medicines. It defines essential medicines as those that satisfy the priority health needs of a population and are selected based on disease prevalence, efficacy, safety and cost-effectiveness. The WHO publishes a Model List of Essential Medicines every two years to guide countries in developing their own lists. Counterfeit medicines pose serious risks as they may contain incorrect ingredients, too much or too little of the active ingredient, or no active ingredient at all. It is difficult to determine the full extent of counterfeiting due to varying reporting methods across countries and regions. Counterfeiting is most prevalent in areas with weak regulatory and enforcement systems for medicines.
OTC Drug Market - Future Growth Driver for IPM
India is one of the emerging markets which is offering significant growth potential for the industry. This presentation provides a glance of Indian Pharmaceutical Market with more insights into Indian OTC drug markets, its current scenario as well as strategies for ensuring higher sales returns.
Generic medicines
Generic medicines are drugs that have the same active ingredients, strength, quality and efficacy as brand name drugs. They must be approved for consumption. The Indian government encourages generic drug manufacturing through policies like allowing process patents and promoting prescriptions by generic drug names. This has made India a leading producer of generic drugs. Generic medicines produced in India are as safe and effective as those produced elsewhere due to stringent global regulations. The government also launched an initiative to make generics more affordable and accessible to all.
National drug policy for BPH
The document discusses Nepal's National Drug Policy. It begins by outlining the objectives of having a national drug policy, which are to ensure equitable access to quality and effective medicines, and their rational use. It then describes the key components of a national drug policy, which generally focus on selection of essential medicines, affordability, supply systems, regulation, rational use, research, human resources, and monitoring and evaluation. The summary concludes by noting that Nepal introduced its first National Drug Policy in 1995, which had positive impacts and led to achievements in access, quality, and rational use of medicines.
National drug-policy of Nepal
This document outlines Nepal's National Drug Policy from 1995. The key points are:
1) The policy aims to ensure access to safe, effective, quality medicines at affordable prices throughout Nepal and make the country self-reliant in drug production.
2) Objectives include evolving mechanisms for reasonable medicine prices, strengthening procurement and distribution systems, ensuring essential medicine supplies, developing pharmacy resources, and promoting rational medicine use.
3) Policy strategies address medicine management, quality assurance, rational use promotion, manpower development, supporting domestic industry, traditional medicines, and research. The policy aims to improve medicine access, availability, and quality in Nepal.
National Drug Policy
National Drug Policy shall focus on effective drug management processes, such as rational drug selection, proper quantification of drug needs at all levels of health care delivery, and effective procurement practices.
Activity ppt (group 89 96) A macro view on INDIA'S PHARMACEUTICAL INDUSTRY & ...
Activity ppt (group 89 96) A macro view on INDIA'S PHARMACEUTICAL INDUSTRY & ...SOURAV MADHAV SURYAWANSHI
The document discusses India's pharmaceutical industry and its globalization. It provides statistics on India's health expenditure, which is only 0.34% of GDP, and its global ranking in pharmaceutical production and exports. India supplies over half of global generic drug demand. The domestic market is valued at $20 billion annually and expected to reach $120-130 billion by 2030. India exports $24 billion in drugs annually, supplying affordable generic drugs and vaccines globally. The industry is supported by government initiatives and expected to grow further. Generic Medicine and its Future Prospects in India
Its is one of the project assigned to us in Rural Marketing!!! Mine topic was Generic Medicine and its future prospects in India keeping in mind the High Expenditure an average Indian has capacity to bear.
Hope its liked and appreciated by people. I will be also sharing a slide with a small online survey I did in this context which will provide a bit more insight in this aspect to everyone.
Hope people will find this useful and informative..
national drug policy 2005 (eng) Bangladesh
The document is Bangladesh's National Drug Policy from 2005. Some key points:
- It aims to ensure access to essential drugs at affordable prices and strengthen drug regulation.
- It outlines objectives like encouraging local production, research and exports. Rational drug use and banning substandard drugs.
- It recommends raising the drug regulatory body, updating drug laws, and setting criteria for registering imported and locally manufactured drugs.
- Criteria include safety, efficacy, quality standards, and allowing some combination drugs and traditional medicines.
A Study of generic drugs
This document is a project report submitted by Mr. Santosh Panchakshari Salgare to the Department of Management Sciences at Savitribai Phule Pune University. The project involved conducting a study to understand the prescription pattern of generic drugs at Hindustan Antibiotics Limited in Pimpri, Pune. The report includes an introduction to the pharmaceutical industry, company profile of Hindustan Antibiotics Limited, objectives, methodology, findings and analysis of the study, and conclusions and recommendations.
Generic medicines promulgating growth and access rev1
Large population of poor people in India, find it difficult to afford the more expensive branded category of medicines. They were fired up by our PM's “Jan Aushadhi” scheme which ensures availability of quality medicines at affordable prices to all.
My students are doing their bit for the country . Appreciate if you could look through their work and encourage them for their future. In case you need to contact them, we have provided the contacts on their project material.
Otc in india
The document discusses over-the-counter (OTC) drugs in India. It states that OTC drugs do not require a prescription and include drugs not listed as prescription-only. Prescription-only drugs are listed in Schedules H and X and require medical supervision. Drugs in Schedule G require labels stating they are dangerous without medical oversight. The Indian OTC market was worth $1.8 billion in 2009 and is projected to grow 10-12% over 5 years. Common OTC products include digestives, analgesics, and vitamins.
Rx to OTC switch by Dr. Zubair Ali
This document discusses factors related to switching medications from prescription to over-the-counter status. It begins by defining Rx-to-OTC switching as transferring FDA-approved prescription medications to non-prescription, over-the-counter status. The document then covers stakeholders impacted by switching, the switching process and principles, factors contributing to successful switches, considerations for switches, and strategies for building brand equity during and after a switch from prescription to over-the-counter status.
Pharmaceutical policy of Nepal
The document summarizes Nepal's National Drug Policy of 1995. The policy's main objectives are to ensure access to safe, effective and affordable medicines throughout Nepal and to develop the country's pharmaceutical sector. It aims to do so through strategies like establishing drug management systems, promoting quality control, rational drug use, developing pharmaceutical workforce, supporting domestic drug industry, and traditional medicines. Progress made includes revising essential medicines lists, establishing quality control laboratories, increasing training, and expanding domestic drug production.
Setting the threshold for reimbursement of a treatment
This document provides information about Dr. Paul Cornes and his conflicts of interest. It discloses that Dr. Cornes receives salary from the UK National Health Service and has received honoraria from several pharmaceutical companies. The document then discusses challenges in setting reimbursement thresholds for new cancer treatments, including that many new drugs approved in 2012 cost over $100,000 annually but provided only small survival benefits. It also considers options for containing future health spending and the need to balance health spending with economic growth.
Generic Drugs
Generic Drugs having low cost. We should know about world drug scenario. In our daily life, we must concern with doctors and take drugs for cure. But we are not aware about drugs.We should know about drugs, not to become a Doctor, but for general awareness or at least to know what we are taking for our helth.
Final
This document provides an overview of research methodology for studying the Indian pharmaceutical market and the effect of healthcare products. The objectives are to understand the market contribution of healthcare products and evaluate consumers' and doctors' attitudes towards these products. Secondary research will gather data from company sources, while primary research will involve interviews with chemists, doctors, and consumers. The study aims to benefit researchers, the sponsoring organization, and colleagues by providing insights into opportunities in the domestic pharmaceutical market.
JAN AUSHADHI SCHEME DETAILS.
The Jan Aushadhi scheme launched by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India aims to make available quality generic medicines at affordable prices to all through special outlet known as Jan Aushadhi store opened/to be opened in each district of all the States. The new business plan approved by the Department of Pharmaceuticals in August, 2013 brought out it no. of changes to make the campaign a real success.
OTC Markets in India 2008-09
- The OTC market in India is estimated at $1.793 billion and accounts for 18% of total pharmaceutical sales. Major OTC categories include aches/pains, cough, colds, hyperacidity, minor infections, and indigestion. Emerging categories include cuts, wounds, burns, muscle pains, sprains, diarrhea, and constipation.
- 700 million Indians lack access to specialist care as 80% of specialists live in urban areas. Private health expenditure as a percentage of GDP is growing at rates of 12.75% in rural areas and 15.15% in urban areas.
- Common OTC products sold in India include analgesics, antacids, vitamins, herbal ton
Nepal pharmaceutical profile
This document provides a pharmaceutical country profile for Nepal. It contains information on health, demographic, socioeconomic, and mortality data as well as details on health services, policy issues, medicines trade, regulation, financing, procurement, rational use, and household access to medicines in Nepal. The profile was developed by the Ministry of Health and Population in collaboration with the World Health Organization to compile relevant existing information on Nepal's pharmaceutical sector in a user-friendly format.
Pharmaceutical industry
This document provides an overview of the global and Indian pharmaceutical industries. It discusses the evolution and growth of the industries from the 1940s to present day. Key points include increased regulation and costs driving consolidation, pressure to develop new drugs, and the industries transforming from US/EU focused to global. The Indian industry is self-reliant in drug production and a low-cost source for generics facing patent expiration globally. The document also outlines regulations and classifications within the industries.
Pharmacist in Industry / Role of a Pharmacist in Industry
youtube link : https://www.youtube.com/channel/UCPHH8m5zlQGLhXgvH755agg?view_as=subscriber
Facebook group : https://www.facebook.com/groups/836761619701557/
Facebook page : https://www.facebook.com/PharmU/
Antibiotic resistance 1
ANTIBIOTIC RESISTANCE IS A MAJOR PROBLEM FACED BY MEDICAL COMMUNITY AND CHALLENGE FOR NATION'S HEALTH POLICY.
CGD/Rachel Nugent Bamako Presentation Consultation Session
The document discusses forming a working group to address the growing problem of drug resistance. The working group would examine factors contributing to drug resistance, differences between diseases and regions, and implications for stakeholders. The goal is to generate policy recommendations for funders, agencies, and developing country policymakers to create a systematic response to drug resistance and slow its spread.
More Related Content
What's hot
Generic medicines
Generic medicines are drugs that have the same active ingredients, strength, quality and efficacy as brand name drugs. They must be approved for consumption. The Indian government encourages generic drug manufacturing through policies like allowing process patents and promoting prescriptions by generic drug names. This has made India a leading producer of generic drugs. Generic medicines produced in India are as safe and effective as those produced elsewhere due to stringent global regulations. The government also launched an initiative to make generics more affordable and accessible to all.
National drug policy for BPH
The document discusses Nepal's National Drug Policy. It begins by outlining the objectives of having a national drug policy, which are to ensure equitable access to quality and effective medicines, and their rational use. It then describes the key components of a national drug policy, which generally focus on selection of essential medicines, affordability, supply systems, regulation, rational use, research, human resources, and monitoring and evaluation. The summary concludes by noting that Nepal introduced its first National Drug Policy in 1995, which had positive impacts and led to achievements in access, quality, and rational use of medicines.
National drug-policy of Nepal
This document outlines Nepal's National Drug Policy from 1995. The key points are:
1) The policy aims to ensure access to safe, effective, quality medicines at affordable prices throughout Nepal and make the country self-reliant in drug production.
2) Objectives include evolving mechanisms for reasonable medicine prices, strengthening procurement and distribution systems, ensuring essential medicine supplies, developing pharmacy resources, and promoting rational medicine use.
3) Policy strategies address medicine management, quality assurance, rational use promotion, manpower development, supporting domestic industry, traditional medicines, and research. The policy aims to improve medicine access, availability, and quality in Nepal.
National Drug Policy
National Drug Policy shall focus on effective drug management processes, such as rational drug selection, proper quantification of drug needs at all levels of health care delivery, and effective procurement practices.
Activity ppt (group 89 96) A macro view on INDIA'S PHARMACEUTICAL INDUSTRY & ...
Activity ppt (group 89 96) A macro view on INDIA'S PHARMACEUTICAL INDUSTRY & ...SOURAV MADHAV SURYAWANSHI
The document discusses India's pharmaceutical industry and its globalization. It provides statistics on India's health expenditure, which is only 0.34% of GDP, and its global ranking in pharmaceutical production and exports. India supplies over half of global generic drug demand. The domestic market is valued at $20 billion annually and expected to reach $120-130 billion by 2030. India exports $24 billion in drugs annually, supplying affordable generic drugs and vaccines globally. The industry is supported by government initiatives and expected to grow further. Generic Medicine and its Future Prospects in India
Its is one of the project assigned to us in Rural Marketing!!! Mine topic was Generic Medicine and its future prospects in India keeping in mind the High Expenditure an average Indian has capacity to bear.
Hope its liked and appreciated by people. I will be also sharing a slide with a small online survey I did in this context which will provide a bit more insight in this aspect to everyone.
Hope people will find this useful and informative..
national drug policy 2005 (eng) Bangladesh
The document is Bangladesh's National Drug Policy from 2005. Some key points:
- It aims to ensure access to essential drugs at affordable prices and strengthen drug regulation.
- It outlines objectives like encouraging local production, research and exports. Rational drug use and banning substandard drugs.
- It recommends raising the drug regulatory body, updating drug laws, and setting criteria for registering imported and locally manufactured drugs.
- Criteria include safety, efficacy, quality standards, and allowing some combination drugs and traditional medicines.
A Study of generic drugs
This document is a project report submitted by Mr. Santosh Panchakshari Salgare to the Department of Management Sciences at Savitribai Phule Pune University. The project involved conducting a study to understand the prescription pattern of generic drugs at Hindustan Antibiotics Limited in Pimpri, Pune. The report includes an introduction to the pharmaceutical industry, company profile of Hindustan Antibiotics Limited, objectives, methodology, findings and analysis of the study, and conclusions and recommendations.
Generic medicines promulgating growth and access rev1
Large population of poor people in India, find it difficult to afford the more expensive branded category of medicines. They were fired up by our PM's “Jan Aushadhi” scheme which ensures availability of quality medicines at affordable prices to all.
My students are doing their bit for the country . Appreciate if you could look through their work and encourage them for their future. In case you need to contact them, we have provided the contacts on their project material.
Otc in india
The document discusses over-the-counter (OTC) drugs in India. It states that OTC drugs do not require a prescription and include drugs not listed as prescription-only. Prescription-only drugs are listed in Schedules H and X and require medical supervision. Drugs in Schedule G require labels stating they are dangerous without medical oversight. The Indian OTC market was worth $1.8 billion in 2009 and is projected to grow 10-12% over 5 years. Common OTC products include digestives, analgesics, and vitamins.
Rx to OTC switch by Dr. Zubair Ali
This document discusses factors related to switching medications from prescription to over-the-counter status. It begins by defining Rx-to-OTC switching as transferring FDA-approved prescription medications to non-prescription, over-the-counter status. The document then covers stakeholders impacted by switching, the switching process and principles, factors contributing to successful switches, considerations for switches, and strategies for building brand equity during and after a switch from prescription to over-the-counter status.
Pharmaceutical policy of Nepal
The document summarizes Nepal's National Drug Policy of 1995. The policy's main objectives are to ensure access to safe, effective and affordable medicines throughout Nepal and to develop the country's pharmaceutical sector. It aims to do so through strategies like establishing drug management systems, promoting quality control, rational drug use, developing pharmaceutical workforce, supporting domestic drug industry, and traditional medicines. Progress made includes revising essential medicines lists, establishing quality control laboratories, increasing training, and expanding domestic drug production.
Setting the threshold for reimbursement of a treatment
This document provides information about Dr. Paul Cornes and his conflicts of interest. It discloses that Dr. Cornes receives salary from the UK National Health Service and has received honoraria from several pharmaceutical companies. The document then discusses challenges in setting reimbursement thresholds for new cancer treatments, including that many new drugs approved in 2012 cost over $100,000 annually but provided only small survival benefits. It also considers options for containing future health spending and the need to balance health spending with economic growth.
Generic Drugs
Generic Drugs having low cost. We should know about world drug scenario. In our daily life, we must concern with doctors and take drugs for cure. But we are not aware about drugs.We should know about drugs, not to become a Doctor, but for general awareness or at least to know what we are taking for our helth.
Final
This document provides an overview of research methodology for studying the Indian pharmaceutical market and the effect of healthcare products. The objectives are to understand the market contribution of healthcare products and evaluate consumers' and doctors' attitudes towards these products. Secondary research will gather data from company sources, while primary research will involve interviews with chemists, doctors, and consumers. The study aims to benefit researchers, the sponsoring organization, and colleagues by providing insights into opportunities in the domestic pharmaceutical market.
JAN AUSHADHI SCHEME DETAILS.
The Jan Aushadhi scheme launched by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India aims to make available quality generic medicines at affordable prices to all through special outlet known as Jan Aushadhi store opened/to be opened in each district of all the States. The new business plan approved by the Department of Pharmaceuticals in August, 2013 brought out it no. of changes to make the campaign a real success.
OTC Markets in India 2008-09
- The OTC market in India is estimated at $1.793 billion and accounts for 18% of total pharmaceutical sales. Major OTC categories include aches/pains, cough, colds, hyperacidity, minor infections, and indigestion. Emerging categories include cuts, wounds, burns, muscle pains, sprains, diarrhea, and constipation.
- 700 million Indians lack access to specialist care as 80% of specialists live in urban areas. Private health expenditure as a percentage of GDP is growing at rates of 12.75% in rural areas and 15.15% in urban areas.
- Common OTC products sold in India include analgesics, antacids, vitamins, herbal ton
Nepal pharmaceutical profile
This document provides a pharmaceutical country profile for Nepal. It contains information on health, demographic, socioeconomic, and mortality data as well as details on health services, policy issues, medicines trade, regulation, financing, procurement, rational use, and household access to medicines in Nepal. The profile was developed by the Ministry of Health and Population in collaboration with the World Health Organization to compile relevant existing information on Nepal's pharmaceutical sector in a user-friendly format.
Pharmaceutical industry
This document provides an overview of the global and Indian pharmaceutical industries. It discusses the evolution and growth of the industries from the 1940s to present day. Key points include increased regulation and costs driving consolidation, pressure to develop new drugs, and the industries transforming from US/EU focused to global. The Indian industry is self-reliant in drug production and a low-cost source for generics facing patent expiration globally. The document also outlines regulations and classifications within the industries.
Pharmacist in Industry / Role of a Pharmacist in Industry
youtube link : https://www.youtube.com/channel/UCPHH8m5zlQGLhXgvH755agg?view_as=subscriber
Facebook group : https://www.facebook.com/groups/836761619701557/
Facebook page : https://www.facebook.com/PharmU/
What's hot (20)
Activity ppt (group 89 96) A macro view on INDIA'S PHARMACEUTICAL INDUSTRY & ...
Activity ppt (group 89 96) A macro view on INDIA'S PHARMACEUTICAL INDUSTRY & ...
Generic Medicine and its Future Prospects in India
Generic Medicine and its Future Prospects in India
Generic medicines promulgating growth and access rev1
Generic medicines promulgating growth and access rev1
Setting the threshold for reimbursement of a treatment
Setting the threshold for reimbursement of a treatment
Pharmacist in Industry / Role of a Pharmacist in Industry
Pharmacist in Industry / Role of a Pharmacist in Industry
Similar to Revisiting Recommendations on Drug Resistance from Past Studies
Antibiotic resistance 1
ANTIBIOTIC RESISTANCE IS A MAJOR PROBLEM FACED BY MEDICAL COMMUNITY AND CHALLENGE FOR NATION'S HEALTH POLICY.
CGD/Rachel Nugent Bamako Presentation Consultation Session
The document discusses forming a working group to address the growing problem of drug resistance. The working group would examine factors contributing to drug resistance, differences between diseases and regions, and implications for stakeholders. The goal is to generate policy recommendations for funders, agencies, and developing country policymakers to create a systematic response to drug resistance and slow its spread.
antimicrobial-prescribing-policy.pdf
This document outlines the Antimicrobial Prescribing Policy for Sherwood Forest Hospitals NHS Foundation Trust. It aims to provide a framework to ensure appropriate antimicrobial use and reduce unnecessary overuse. Key points include: establishing an Antimicrobial Prescribing Working Group to develop guidelines and monitor use; defining roles for prescribers, nurses, pharmacists and microbiologists in ensuring prudent antimicrobial prescribing; standards for documentation of antimicrobial prescriptions; and requirements for review of treatment and consideration of switching from IV to oral routes when possible. The policy aims to support optimal antimicrobial stewardship across the Trust.
Antimicrobial Stewardship
The document discusses antibiotic stewardship programs in hospitals. It describes the core elements of such programs, including establishing guidelines and protocols for optimal antibiotic use, educating staff, and monitoring antibiotic use and resistance. It also outlines strategies hospitals use like prospective audits, formulary restrictions, education, and developing order sets. The challenges of implementing and sustaining antibiotic stewardship programs are also examined.
Who antibiotic policy
The document provides guidance on developing an antibiotic policy and standard treatment guidelines for a hospital. It recommends establishing a multidisciplinary antibiotic management team to draft the policy. The team should review available evidence-based policies and guidelines and adapt them to the local context. The policy should provide recommendations for optimal antibiotic selection, dosage, duration and alternatives based on local antimicrobial resistance patterns. It should also address prophylactic use, identify gaps in evidence, and establish processes for regular review and updating the policy. The overall aim is to promote rational antibiotic use and reduce antimicrobial resistance.
Antibiotic Stewardship in Inpatient Settings Quality Improvement Proposal.docx
This quality improvement proposal aims to address the problem of antibiotic resistance in inpatient hospital settings. It proposes implementing an antibiotic stewardship program (ASP) using the PDSA cycle approach. ASPs are shown to reduce inappropriate antibiotic use and circulating resistant bacteria strains, lowering mortality from infections. The proposal outlines steps for establishing an ASP based on CDC guidelines, including leadership commitment, pharmacist involvement, tracking use and resistance data. Program success will be evaluated using statistical tests comparing antibiotic use and positive blood cultures for resistant bacteria, with the goal of reducing defects in line with Six Sigma principles.
Who antibiotic policy iihmr jaipur
The document outlines World Health Organization (WHO) guidelines for developing an antibiotic policy and strategies to promote rational antibiotic use in hospitals. It discusses establishing an antimicrobial resistance (AMR) surveillance system, developing standard treatment guidelines based on a cumulative antibiogram, and forming an antimicrobial management team. The document emphasizes optimizing antibiotic treatment duration and type based on culture/sensitivity results and instituting antimicrobial stewardship programs.
Dr. Lauri Hicks - Out-Patient Antibiotic Resistance (AMR) Issues
Out-Patient Antibiotic Resistance (AMR) Issues - Dr. Lauri Hicks, Commander, U.S. Public Health Service, Medical Epidemiologist, Respiratory Diseases Branch; Medical Director, Get smart: Know When Antibiotic Work Program; Centers for Disease Control and Prevention (CDC), from the 2015 NIAA Antibiotic Symposium - Stewardship: From Metrics to Management, November 3-5, 2015, Atlanta, Georgia, USA.
More presentations at http://swinecast.com/2015-niaa-symposium-antibiotics-stewardship-from-metrics-to-management
CDC-core-elements.pdf
The document outlines the core elements of effective hospital antibiotic stewardship programs. It recommends that programs appoint a physician leader and pharmacist leader to be accountable for the program. Programs should implement at least one action to improve antibiotic use, such as reviewing ongoing treatment need after an initial period. They should also track antibiotic prescribing patterns, report information on use and resistance to clinicians, and provide education to physicians about appropriate antibiotic prescribing. Leadership support, multi-disciplinary collaboration, and resources are keys to success.
Dr. James Hughes - Combating Antimicrobial Resistance: The Way Forward
Combating Antimicrobial Resistance: The Way Forward - Dr. James Hughes, Professor of Medicine and Public Health with Joint Appointments in the School of Medicine and the Rollins School of Public Health at Emory University, from the 2014 NIAA Symposium on Antibiotics Use and Resistance: Moving Forward Through Shared Stewardship, November 12-14, 2014, Atlanta, Georgia, USA.
More presentations at http://www.swinecast.com/2014-niaa-antibiotics-moving-forward-through-shared-stewardship
5 Direct Practice Improvement Project ProspectusAntim.docx
5
Direct Practice Improvement Project Prospectus
Antimicrobial Stewardship program (ASP): An evidence based quality assurance measure in combating Healthcare Associated Clostridium Difficile Infection in an acute care facility and the role of the Staff Nurse.
Submitted by
Date
Insert Chairperson Name
Prospectus Instructions:
1. Read the entire Prospectus Template to understand the requirements for writing your Prospectus. Each section contains a narrative overview of what should be included in the section and a table with criteria required for each section. These criteria will be used to assess the prospectus for overall quality and feasibility of the proposed research study.
2. As you draft each section, delete the narrative instructions and insert your work related to that section. Use the criteria table for each section to ensure that you address the requirements for that particular section. Do not delete/remove the criteria table as this is used by you and your Committee to evaluate your prospectus.
3. Prior to submitting your prospectus for review by your Chair or Methodologist, use the criteria table for each section to complete a self-evaluation, inserting what you believe is your score for each listed criteria into the Learner Self-Evaluation column.
4. The scoring for the criteria ranges from a 0-3 as defined below. Complete a realistic and thoughtful evaluation of your work. Your Chair and Methodologist will also use the criteria tables to evaluate your work.
5. Your Prospectus should be between 6-10 pages when the tables are deleted.
Score
Assessment
0
Item Not Present
1
Item is Present, But Does Not Meet Expectations: Not all components are present. Large gaps are present in the components that leave the reader with significant questions. All items scored at 1 must be addressed by learner per reviewer comments.
2
Item Approaches Meeting Expectations, But Needs Revision: Component is present and adequate. Small gaps are present that leave the reader with questions. Any item scored at 2 must be addressed by the learner per the reviewer comments.
3
Item Meets Expectations: Component is addressed clearly and comprehensively. No gaps are present that leave the reader with questions. No changes required.
2
Introduction
The world today is faced with very dangerous infectious diseases due to antibiotic resistance and in the United States, the Centers for Disease Control and Prevention (CDC), has named this escalating antibiotic resistance as one of the top five threats in the country (CDC, 2017). According to statistics from the CDC, drug-resistant bacteria cause more than 20, 000 deaths annually and result to 2 million cases of disease recurrence annually (Lagier et al., 2015). For this reason, there is an increased need to make changes to the clinical practice to encourage appropriate use of antibiotics. In late 2014, the President’s Council of Advisors on Science and Technology (PCAST) published a report on how to combat.
www.medicotesting.com , AIDS ppt
The document discusses anti-retroviral drug resistance in HIV. It notes that drug resistance is a major reason why HIV drugs stop being effective over time. It outlines steps India is taking to monitor and prevent drug resistance, including establishing a national committee on HIV drug resistance to develop surveillance strategies. Pilot sites for initial threshold surveys and drug resistance monitoring are proposed to provide initial data on transmission levels and resistance in patients on antiretroviral therapy.
Antibiotic Policy - An Overview
Antimicrobial resistance has emerged as a major public health problem worldwide. Infections caused by resistant microbes are difficult to treat, prolonging illness and increasing mortality risk. This also leads to longer periods of infectivity, exposing more people to resistant strains. When microbes become resistant to first-line drugs, second-line drugs may be too expensive for many to access treatment. Multidrug-resistant infections are virtually untreatable, creating a "post-antibiotic era." Healthcare facilities must establish antibiotic management teams and policies to minimize antimicrobial resistance and preserve antibiotic effectiveness. Policies should be evidence-based, regularly reviewed, and aligned with national policies while accounting for local resistance patterns.
Antibiotic Stewardship: Current status and implications in India
Antibiotic Stewardship: Current status and implications in India. This presentation gives an overview of Antibiotics: components, prescription, selection etc.
Pharmacovigilance
Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. WHO established its Programme for International Drug Monitoring in response to the thalidomide disaster detected in 1961. Together with the WHO Collaborating Centre for International Drug Monitoring, Uppsala, WHO promotes PV at the country level. At the end of 2010, 134 countries were part of the WHO PV Programme. The aims of PV are to enhance patient care and patient safety in relation to the use of medicines; and to support public health programmes by providing reliable, balanced information for the effective assessment of the risk-benefit profile of medicines.
Dr. Tom Shryock - Role of the Presidential Advisory Council on Combating Anti...
Role of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria - Dr. Tom Shryock, Chief Scientific Officer, Antimicrobial Consultants, from the 2016 NIAA Antibiotic Symposium - Working Together For Better Solutions, November 1 - 3, 2016, Herndon, Virginia, USA.
More presentations at http://www.swinecast.com/2016-niaa-symposium-antibiotic-use-working-together-for-better-solutions
Policy recommendations for improved medication adherence in Europe: the ABC P...
Policy recommendations for improved medication adherence in Europe: the ABC P...Global Risk Forum GRFDavos
GRF One Health Summit 2012, Davos: Presentation by Przemyslaw KARDAS, Medical University of Lodz, Poland, Republic ofMichael Craig - Updates from the CDC
Updates from the CDC - Michael Craig, Senior Advisor for Antibiotic Resistance Coordination and Strategy, National Center for Emerging and Zoonotic Infectious Diseases, CDC, from the 2016 NIAA Antibiotic Symposium - Working Together For Better Solutions, November 1 - 3, 2016, Herndon, Virginia, USA.
More presentations at http://www.swinecast.com/2016-niaa-symposium-antibiotic-use-working-together-for-better-solutions
Hospital Antibiotic Stewardship Programs - Qualitative analysis of numerous h...
Antimicrobial stewardship programs (ASP) are an essential practice to prevent increasing
resistance against antibiotics. A successful ASP monitors not only prescribing patterns and
practices but also contributes in minimizing the toxic effects of antibiotics. Moreover, ASP
also facilitates the selection of disease specific antibiotics and enforces rules and regulations to rationalize the use of antibiotics. The aim of the study is to highlight the core
elements of Hospital Antibiotic Stewardship Programs in Karachi. The key elements proposed by center of disease control (CDC) such as; leadership, accountability, drug
expertise, actions to support optimal antibiotic use, tracking (monitoring antibiotic prescribing, use and resistance), reporting information to staff on improving antibiotic use
and resistance and education were evaluated on Yes/No scale. The data was collected
from 44 hospitals of different categories in Karachi and all the major elements were
studied. It was observed that all the hospitals in one setting failed to comply with all the
guidelines. It has been concluded that efforts should be made to design ASP at each
hospital and implemented through suitable policies and procedures.
Anti microbial program nepal
This document presents Nepal's National Antimicrobial Resistance Containment Action Plan for 2016. It outlines the growing threat of antimicrobial resistance in Nepal due to overuse and misuse of antibiotics. Laboratory surveillance data from 20 participating labs shows increasing resistance to common antibiotics used to treat Salmonella, Shigella, pneumococci and other bacteria. The plan establishes 5 strategic objectives to address antimicrobial resistance through improved surveillance, stewardship, infection prevention, research and regional/international cooperation. It recognizes that containing antimicrobial resistance requires a coordinated one health approach across government agencies, private sectors and other stakeholders.
Similar to Revisiting Recommendations on Drug Resistance from Past Studies (20)
CGD/Rachel Nugent Bamako Presentation Consultation Session
CGD/Rachel Nugent Bamako Presentation Consultation Session
Antibiotic Stewardship in Inpatient Settings Quality Improvement Proposal.docx
Antibiotic Stewardship in Inpatient Settings Quality Improvement Proposal.docx
Dr. Lauri Hicks - Out-Patient Antibiotic Resistance (AMR) Issues
Dr. Lauri Hicks - Out-Patient Antibiotic Resistance (AMR) Issues
Dr. James Hughes - Combating Antimicrobial Resistance: The Way Forward
Dr. James Hughes - Combating Antimicrobial Resistance: The Way Forward
5 Direct Practice Improvement Project ProspectusAntim.docx
5 Direct Practice Improvement Project ProspectusAntim.docx
Antibiotic Stewardship: Current status and implications in India
Antibiotic Stewardship: Current status and implications in India
Dr. Tom Shryock - Role of the Presidential Advisory Council on Combating Anti...
Dr. Tom Shryock - Role of the Presidential Advisory Council on Combating Anti...
Policy recommendations for improved medication adherence in Europe: the ABC P...
Policy recommendations for improved medication adherence in Europe: the ABC P...
Hospital Antibiotic Stewardship Programs - Qualitative analysis of numerous h...
Hospital Antibiotic Stewardship Programs - Qualitative analysis of numerous h...
Recently uploaded
Journal Article Review on Rasamanikya
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
A Classical Text Review on Basavarajeeyam
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
It includes regulation of combination products and medical devices. FDA and industry liaisons.
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Physiology of Special Chemical Sensation of Taste
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Top-Vitamin-Supplement-Brands-in-India List
Swisschem Dermacare provides the Top 10 Vitamin Supplement Brands in India. To know more about us give us call at our official number
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxMGM SCHOOL/COLLEGE OF NURSING
Identification and nursing management of congenital malformations ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
PPT RELATED TO ARTHROLOGY ACCORDING TO NCISM AYURVEDA
Top Effective Soaps for Fungal Skin Infections in India
Swisschem Dermacare has mentioned the List of The Best Antifungal Soap In India 2022. All of these soaps are trusted by various Dermatology Experts.
Top 10 Best Ayurvedic Kidney Stone Syrups in India
we have mentioned the best 10 ayurvedic Kidney Stone Syrups. You can check all these products and choose the best one for yourself.
Non-respiratory Functions of the Lungs.pdf
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Physiology of Chemical Sensation of smell.pdf
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
micro teaching on communication m.sc nursing.pdf
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
ABDOMINAL TRAUMA in pediatrics part one.
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
Recently uploaded (20)
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Revisiting Recommendations on Drug Resistance from Past Studies
- 1. Revisiting Recommendations Jessica Pickett Drug Resistance Working Group March 7, 2008
- 26. Health Systems Which recommendations have been successful? Which ones haven’t? Why not?
- 38. Behavior Which recommendations have been successful? Which ones haven’t? Why not?
- 54. Technology Which recommendations have been successful? Which ones haven’t? Why not?
- 55. Opportunities for Impact Where should the Working Group focus? And what can we do differently?
- 56. ANNEX A Recommendations: External Factors
- 63. ANNEX B APUA Synthesis Report